Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Excretion of Rivaroxaban in Human Breast Milk

NCT06831474 is registered in ClinicalTrials.gov with Thomas Jefferson University as lead sponsor.

NCT NCT06831474
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06831474 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Excretion of Rivaroxaban in Human Breast Milk
Lead sponsor
Thomas Jefferson University
Phase
Phase 1
Overall status
Recruiting
Start date
July 31, 2025
Completion date
July 31, 2026
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast milk collection, breastfeeding, postpartum, rivaroxaban, vte (venous thromboembolism), vte prophylaxis